TMCI — Treace Medical Concepts, Inc. Stock Price, Chart & AI Report

Negative Dec 1, 2025 • 22:44 UTC GlobeNewswire Inc. • Johnson Fistel, Pllp

Johnson Fistel, PLLP Investigates Claims on Behalf of Long‑Term Shareholders of Quantum Computing Inc. (QUBT), Quanex Building Products Corporation (NX), Treace Medical Concepts, Inc. (TMCI), and BigBear.ai Holdings, Inc. (BBAI)

Law firm Johnson Fistel is investigating potential securities fraud and breaches of fiduciary duties for four publicly traded companies, alleging false statements, misleading disclosures, and operational misrepresentations.

QUBT NX TMCI BBAI securities fraud shareholder rights class action lawsuit fiduciary duties

Sentiment note

Allegations of product demand challenges and revenue decline due to competitive pressures

Negative Sep 26, 2025 • 13:04 UTC Benzinga • Globe Newswire

Important Notice to Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); RCI Hospitality Holdings, Inc. (NASDAQ: RICK); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf

Grabar Law Office is investigating potential shareholder claims against four companies, alleging various corporate misconduct including false financial statements, misleading disclosures, and potential breaches of fiduciary duties.

DV RICK TMCI LUXHQ shareholder investigation securities fraud corporate misconduct legal claims

Sentiment note

Claims of misleading statements about product demand, revenue decline, and lack of competitive product alternatives

Neutral Aug 8, 2025 • 02:20 UTC The Motley Fool • Jesterai

Treace Medical (TMCI) Q2 Revenue Up 7%

Treace Medical Concepts reported Q2 2025 earnings with a 7% revenue increase, narrowing net losses and expanding its bunion correction product portfolio. The company maintained its full-year revenue guidance and aims to target more bunion procedure markets.

TMCI medical devices bunion correction surgical systems earnings report product expansion

Sentiment note

Mixed financial performance with modest revenue growth, narrowing losses, and strategic product expansion, but still not profitable and facing ongoing market challenges

Negative Jul 10, 2025 • 21:31 UTC GlobeNewswire Inc. • Joshua H. Grabar

Important Notice to Long-Term Shareholders of Methode Electronics, Inc. (NYSE: MEI); Manhattan Associates, Inc. (NASDAQ: MANH); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigating Claims on Your Behalf

Grabar Law Office is investigating potential securities fraud and fiduciary breaches for several publicly traded companies, alleging misleading statements, financial misrepresentations, and operational issues that impacted investor confidence.

MEI MANH NSSC TMCI securities fraud shareholder investigation corporate governance financial misrepresentation

Sentiment note

Allegations of misleading statements about product demand and revenue decline

Negative Jun 13, 2025 • 20:47 UTC GlobeNewswire Inc. • N/A

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Manhattan Associates, Inc. (NASDAQ: MANH); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)

Grabar Law Office is investigating potential breaches of fiduciary duties by officers and directors of DoubleVerify, Manhattan Associates, Treace Medical Concepts, and Virtu Financial, based on allegations of misleading statements and failure to disclose material information.

DV MANH TMCI VIRT DoubleVerify Manhattan Associates Treace Medical Concepts Virtu Financial

Sentiment note

The article indicates that a securities class action complaint alleges Treace Medical Concepts failed to disclose that competition impacted the demand for its primary product, leading to revenue declines and the need to accelerate plans for an alternative product.

Negative Jun 9, 2025 • 14:50 UTC Benzinga • Prnewswire

TMCI Investors Have Final Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Treace Medical Concepts, Inc. (TMCI) is facing a securities fraud lawsuit alleging the company made false and misleading statements about its Lapiplasty 3D Bunion Correction System, leading to investor losses.

TMCI Treace Medical Concepts securities fraud Lapiplasty 3D Bunion Correction System

Sentiment note

The company is facing a securities fraud lawsuit alleging it made false and misleading statements about its Lapiplasty 3D Bunion Correction System, leading to investor losses.

Negative Jun 9, 2025 • 08:35 UTC Benzinga • Prnewswire

TMCI Investors Have Final Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Treace Medical Concepts, Inc. (TMCI) is facing a securities fraud lawsuit alleging the company made false and misleading statements about its Lapiplasty 3D Bunion Correction System, leading to investor losses.

TMCI Treace Medical Concepts securities fraud Lapiplasty 3D Bunion Correction System

Sentiment note

The company is facing a securities fraud lawsuit alleging it made false and misleading statements about its Lapiplasty 3D Bunion Correction System, leading to investor losses.

Negative Jun 8, 2025 • 21:40 UTC GlobeNewswire Inc. • N/A

מועד אחרון לתביעה נגד TMCI: רוזן, יועץ משפטי לאומי, מעודד את משקיעי Treace Medical Concepts, Inc. שצברו הפסדים העולים על 100 אלף דולר, להבטיח ייעוץ לפני המועד האחרון החשוב של 10 ביוני בתביעה ייצוגית בניירות ערך – TMCI

Rosen Law Firm reminds Treace Medical Concepts, Inc. (TMCI) investors with losses over $100K to seek legal counsel before the June 10 deadline for a securities class action lawsuit. The lawsuit alleges TMCI made false and misleading statements about its business and financial performance.

TMCI Treace Medical Concepts securities class action investor losses

Sentiment note

The article discusses a securities class action lawsuit against Treace Medical Concepts, alleging the company made false and misleading statements about its business and financial performance, which resulted in investor losses.

Negative Jun 6, 2025 • 13:11 UTC Benzinga • Prnewswire

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating potential securities law violations by Treace Medical Concepts, Inc. (TMCI) and is encouraging affected investors to join the investigation.

TMCI Treace Medical Concepts fraud investigation securities law violations

Sentiment note

The article states that the Schall Law Firm is investigating potential securities law violations by Treace Medical Concepts, Inc., indicating potential issues with the company's disclosures or practices.

Negative Jun 5, 2025 • 17:38 UTC GlobeNewswire Inc. • Law Offices Of Howard G. Smith

DEADLINE ALERT for TMCI, IBTA, NPWR: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law Offices of Howard G. Smith has filed class action lawsuits on behalf of shareholders of Treace Medical Concepts, Inc. (TMCI), Ibotta, Inc. (IBTA), and NET Power Inc. (NPWR) due to alleged securities fraud. Investors have until the specified deadlines to file as lead plaintiffs.

TMCI IBTA NPWR NPWR.WS Treace Medical Concepts Ibotta NET Power securities fraud

Sentiment note

The complaint alleges that the company made false and/or misleading statements about the impact of competition on the demand for its primary product, the Lapiplasty 3D Bunion Correction System, and the need to accelerate plans to offer an alternative product.

Negative Jun 5, 2025 • 17:00 UTC GlobeNewswire Inc. • N/A

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit – TMCI

Levi & Korsinsky notifies investors in Treace Medical Concepts, Inc. (TMCI) of a class action securities lawsuit alleging the company made false statements and concealed information about declining demand for its primary product and the need to accelerate plans for an alternative product.

TMCI Treace Medical Concepts class action lawsuit securities fraud

Sentiment note

The article alleges that the company made false statements and concealed information about declining demand for its primary product and the need to accelerate plans for an alternative product, which suggests negative sentiment.

Negative May 30, 2025 • 20:08 UTC Benzinga • Prnewswire

Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Treace Medical Concepts, Inc. (TMCI) is facing a securities fraud lawsuit alleging that the company failed to disclose competition impacting the demand for its primary product, the Lapiplasty 3D Bunion Correction System, leading to a decline in revenue and the need to accelerate plans for an alternative product.

TMCI Treace Medical Concepts securities fraud Lapiplasty 3D Bunion Correction System

Sentiment note

The article reports that Treace Medical Concepts is facing a securities fraud lawsuit, alleging that the company failed to disclose important information to investors, leading to losses.